Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

295 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Esophageal cancer.
Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Ilson DH, Kleinberg LR, McAleer MF, Meropol NJ, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Swisher SG, Washington MK, Willett C, Wood DE, Wright CD, Yang G; NCCN Esophageal Cancer Panel. Ajani JA, et al. Among authors: meropol nj. J Natl Compr Canc Netw. 2008 Oct;6(9):818-49. J Natl Compr Canc Netw. 2008. PMID: 18926093 No abstract available.
Esophageal cancer. Clinical practice guidelines in oncology.
Ajani J, D'Amico TA, Hayman JA, Meropol NJ, Minsky B; National Comprehensive Cancer Network. Ajani J, et al. Among authors: meropol nj. J Natl Compr Canc Netw. 2003 Jan;1(1):14-27. doi: 10.6004/jnccn.2003.0004. J Natl Compr Canc Netw. 2003. PMID: 19764147
Gastric cancer. Clinical practice guidelines in oncology.
Ajani J, D'Amico TA, Hayman JA, Meropol NJ, Minsky B; National Comprehensive Cancer Network. Ajani J, et al. Among authors: meropol nj. J Natl Compr Canc Netw. 2003 Jan;1(1):28-39. doi: 10.6004/jnccn.2003.0005. J Natl Compr Canc Netw. 2003. PMID: 19764148
Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2.
Spratlin JL, Cohen RB, Eadens M, Gore L, Camidge DR, Diab S, Leong S, O'Bryant C, Chow LQ, Serkova NJ, Meropol NJ, Lewis NL, Chiorean EG, Fox F, Youssoufian H, Rowinsky EK, Eckhardt SG. Spratlin JL, et al. Among authors: meropol nj. J Clin Oncol. 2010 Feb 10;28(5):780-7. doi: 10.1200/JCO.2009.23.7537. Epub 2010 Jan 4. J Clin Oncol. 2010. PMID: 20048182 Free PMC article. Clinical Trial.
Phase I assessment of new mechanism-based pharmacodynamic biomarkers for MLN8054, a small-molecule inhibitor of Aurora A kinase.
Chakravarty A, Shinde V, Tabernero J, Cervantes A, Cohen RB, Dees EC, Burris H, Infante JR, Macarulla T, Elez E, Andreu J, Rodriguez-Braun E, Rosello S, von Mehren M, Meropol NJ, Langer CJ, ONeil B, Bowman D, Zhang M, Danaee H, Faron-Yowe L, Gray G, Liu H, Pappas J, Silverman L, Simpson C, Stringer B, Tirrell S, Veiby OP, Venkatakrishnan K, Galvin K, Manfredi M, Ecsedy JA. Chakravarty A, et al. Among authors: meropol nj. Cancer Res. 2011 Feb 1;71(3):675-85. doi: 10.1158/0008-5472.CAN-10-1030. Epub 2010 Dec 10. Cancer Res. 2011. PMID: 21148750 Clinical Trial.
A Web-based communication aid for patients with cancer: the CONNECT Study.
Meropol NJ, Egleston BL, Buzaglo JS, Balshem A, Benson AB 3rd, Cegala DJ, Cohen RB, Collins M, Diefenbach MA, Miller SM, Fleisher L, Millard JL, Ross EA, Schulman KA, Silver A, Slater E, Solarino N, Sulmasy DP, Trinastic J, Weinfurt KP. Meropol NJ, et al. Cancer. 2013 Apr 1;119(7):1437-45. doi: 10.1002/cncr.27874. Epub 2013 Jan 18. Cancer. 2013. PMID: 23335150 Free PMC article. Clinical Trial.
295 results